BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7724524)

  • 1. The retinoblastoma-susceptibility gene product binds directly to the human TATA-binding protein-associated factor TAFII250.
    Shao Z; Ruppert S; Robbins PD
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3115-9. PubMed ID: 7724524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rb inhibits the intrinsic kinase activity of TATA-binding protein-associated factor TAFII250.
    Siegert JL; Robbins PD
    Mol Cell Biol; 1999 Jan; 19(1):846-54. PubMed ID: 9858607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 associates with the TBP-associated factor TAF(II)250 to regulate Sp1-mediated transcription.
    Adnane J; Shao Z; Robbins PD
    Oncogene; 1999 Jan; 18(1):239-47. PubMed ID: 9926939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 suppresses retinoblastoma protein-mediated inhibition of TAFII250 kinase activity.
    Siegert JL; Rushton JJ; Sellers WR; Kaelin WG; Robbins PD
    Oncogene; 2000 Nov; 19(50):5703-11. PubMed ID: 11126356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAFII250-dependent transcription of cyclin A is directed by ATF activator proteins.
    Wang EH; Zou S; Tjian R
    Genes Dev; 1997 Oct; 11(20):2658-69. PubMed ID: 9334328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter-selective transcriptional defect in cell cycle mutant ts13 rescued by hTAFII250.
    Wang EH; Tjian R
    Science; 1994 Feb; 263(5148):811-4. PubMed ID: 8303298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ts13 mutation in the TAF(II)250 subunit (CCG1) of TFIID directly affects transcription of D-type cyclin genes in cells arrested in G1 at the nonpermissive temperature.
    Suzuki-Yagawa Y; Guermah M; Roeder RG
    Mol Cell Biol; 1997 Jun; 17(6):3284-94. PubMed ID: 9154827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCG1/TAF(II)250 regulates epidermal growth factor receptor gene transcription in cell cycle mutant ts13.
    Vargas GA; Isas JM; Fantino E; Gargus JJ; Haigler HT
    J Cell Physiol; 1998 Sep; 176(3):642-7. PubMed ID: 9699517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of the human TAFII250 N-terminal kinase domain.
    O'Brien T; Tjian R
    Mol Cell; 1998 May; 1(6):905-11. PubMed ID: 9660973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and expression of human TAFII250: a TBP-associated factor implicated in cell-cycle regulation.
    Ruppert S; Wang EH; Tjian R
    Nature; 1993 Mar; 362(6416):175-9. PubMed ID: 7680771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-type cyclin expression is decreased and p21 and p27 CDK inhibitor expression is increased when tsBN462 CCG1/TAFII250 mutant cells arrest in G1 at the restrictive temperature.
    Sekiguchi T; Noguchi E; Hayashida T; Nakashima T; Toyoshima H; Nishimoto T; Hunter T
    Genes Cells; 1996 Jul; 1(7):687-705. PubMed ID: 9078394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class I genes.
    Weissman JD; Brown JA; Howcroft TK; Hwang J; Chawla A; Roche PA; Schiltz L; Nakatani Y; Singer DS
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11601-6. PubMed ID: 9751712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB.
    Hagemeier C; Bannister AJ; Cook A; Kouzarides T
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1580-4. PubMed ID: 8434021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators.
    Chen JL; Attardi LD; Verrijzer CP; Yokomori K; Tjian R
    Cell; 1994 Oct; 79(1):93-105. PubMed ID: 7923382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin-activating/conjugating activity of TAFII250, a mediator of activation of gene expression in Drosophila.
    Pham AD; Sauer F
    Science; 2000 Sep; 289(5488):2357-60. PubMed ID: 11009423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimum essential region of CCG1/TAFII250 required for complementing the temperature-sensitive cell cycle mutants, tsBN462 and ts13 cells, of hamster BHK21 cells.
    Noguchi E; Sekiguchi T; Nohiro Y; Hayashida T; Hirose E; Hayashi N; Nishimoto T
    Somat Cell Mol Genet; 1994 Nov; 20(6):505-13. PubMed ID: 7892648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pX, the HBV-encoded coactivator, suppresses the phenotypes of TBP and TAFII250 mutants.
    Haviv I; Matza Y; Shaul Y
    Genes Dev; 1998 Apr; 12(8):1217-26. PubMed ID: 9553050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator.
    Chen LI; Nishinaka T; Kwan K; Kitabayashi I; Yokoyama K; Fu YH; Grünwald S; Chiu R
    Mol Cell Biol; 1994 Jul; 14(7):4380-9. PubMed ID: 8007947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subregions of the adenovirus E1A transactivation domain target multiple components of the TFIID complex.
    Geisberg JV; Chen JL; Ricciardi RP
    Mol Cell Biol; 1995 Nov; 15(11):6283-90. PubMed ID: 7565781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus 1 late gene expression is preferentially inhibited during infection of the TAF250 mutant ts13 cell line.
    Dhar S; Weir JP
    Virology; 2000 Apr; 270(1):190-200. PubMed ID: 10772991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.